# NEMLUVIO

NDC: 0299-6220
Generic name: nemolizumab-ilto
Labeler / Manufacturer: Galderma Laboratories, L.P.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240813

FDA application: BLA761390

## Active ingredients

- NEMOLIZUMAB: 30 mg/100mg

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0299-6220"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0299-6220
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9229ef1-ac60-4c24-afb6-009d3c781687